Close Menu

NEW YORK (GenomeWeb) – Biogen Idec and Columbia University Medical Center today announced they have signed a $30 million agreement to establish a research facility to study the genetics of disease and find new drug targets.

The partners will build a sequencing and analysis facility and create a postdoctoral program at Columbia to support collaborative genetics studies. The agreement, they said, brings together genomics research conducted at Columbia with Biogen's expertise in discovering new medicines.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.